HHS watchdog office steps up focus on drug pricing
(By Ed Silverman for STAT) Seeking to address rising concerns about prescription medicines, the watchdog arm of the US Department
Read More(By Ed Silverman for STAT) Seeking to address rising concerns about prescription medicines, the watchdog arm of the US Department
Read More(By Andrew Joseph and Casey Ross for STAT) Governors are anticipating gaining more authority over the massive Medicaid health program
Read MoreIn a recent report by the Bipartisan Policy Center’s Senior Health and Housing Task Force, we are unprepared for the
Read More(By Damian Garde for STAT) It’s hard to escape the din of the nation’s prognostication industry coming to terms with
Read More(By Shefali Luthra for Kaiser Health News) It’s been a tumultuous presidential campaign, with the outcome billed as a “change”
Read MoreIn Toni King’s column, he explains the difference between a Medicare Supplement and a Medicare Advantage PPO plan. Read column
Read MoreHumana will expand their collaboration with MDLive to make telemedicine services available to Medicare Advantage members in Georgia and South
Read MoreIn Karen Tellen-Lawton’s column, she gives a little background information on Medicare in effort to help the reader to understand
Read More(By Julie Rovner for Kaiser Health News) Throughout the campaign, President-Elect Donald Trump’s entire health message consisted of promising to
Read More(By Dylan Scott for STAT) WASHINGTON — Should President Donald Trump make drug makers relieved? Or anxious? Continue reading article here… Notice:
Read More